Viewing Study NCT05241132


Ignite Creation Date: 2025-12-24 @ 9:42 PM
Ignite Modification Date: 2025-12-28 @ 12:50 AM
Study NCT ID: NCT05241132
Status: UNKNOWN
Last Update Posted: 2022-02-15
First Post: 2022-01-23
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Tislelizumab Combined With Chemotherapy in the Treatment of Bone Metastases of Unknown Primary
Sponsor: Wei Xu
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module